BMS supports Light the Night event
July 20, 2021
Why support of Light The Night is ‘at the heart of Bristol Myers Squibb’ >
Evolving Needs of People with Beta Thalassemia
June 03, 2021
Evolving Needs of People with Beta Thalassemia >
Bristol Myers Squibb researchers conducting a lab tour in 2019
March 22, 2021
Multiple myeloma action month: innovation and research >
Patients have a single goal: The best care possible. But too often African American patients with multiple myeloma aren’t getting it
January 14, 2021
Patients have a single goal: The best care possible. But too often African American patients with multiple myeloma aren’t getting it >
Team BMS surpasses fundraising goal for Light The Night
December 18, 2020
Team BMS surpasses fundraising goal for Light The Night >
In Cellular Therapy, Patients and Physicians are Always Learning
December 01, 2020
In Cellular Therapy, Patients and Physicians Are Always Learning >
Cell Therapy: Looking to the Future of CAR T
November 11, 2020
Cell Therapy: Looking to the Future of CAR T >
Improving Patients’ Lives Through Cell Therapy Research and Development – Kristen Hege
September 24, 2020
Improving Patients’ Lives Through Cell Therapy Research and Development – Kristen Hege >
Raising Awareness about Blood Cancers: A Diverse and Complex Group of Diseases
August 31, 2020
Raising Awareness about Blood Cancers: A Diverse and Complex Group of Diseases >
December 05, 2019
Growing up with beta-thalassemia: Taking charge of your care >
Understanding the Complexities of a Myelofibrosis Diagnosis
October 18, 2019
Understanding the Complexities of a Myelofibrosis Diagnosis >
Ruben Mesa, M.D., From The Ut Health San Antonio Md Anderson Cancer Center, Believes Ongoing Research In Myelofibrosis Offers Hope That There Will Be More Treatment Options In The Future.
March 25, 2019
Why Myelofibrosis Remains Difficult to Treat >